Surveillance of influenza isolates for susceptibility to neuraminidase inhibitors during the 2000–2002 influenza seasons-Reference-Cited by-同舟云学术

Surveillance of influenza isolates for susceptibility to neuraminidase inhibitors during the 2000–2002 influenza seasons

Published:2004-07 Issue:1-2 Volume:103 Page:195-197
ISSN:0168-1702
Container-title:Virus Research
language:en
Short-container-title:Virus Research

Author:

Mungall Bruce A,Xu Xiyan,Klimov Alexander

Publisher

Elsevier BV

Subject

Cancer Research,Infectious Diseases,Virology

Reference7 articles.

1. Development of a sensitive chemiluminescent neuraminidase assay for the determination of influenza virus susceptibility to zanamivir;Buxton;Anal. Biochem.,2000

2. Phenotypic and genotypic assay of influenza virus neuraminidase indicates a low incidence of viral drug resistance during treatment with oseltamivir;Covington;J. Clin. Virol.,2000

3. Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en;Gubareva;J. Virol.,1997

4. Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus;Gubareva;J. Infect. Dis.,1998

5. Management of influenza: use of new antivirals and resistance in perspective;Jackson;Clin. Drug Invest.,2000

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting Permissive Mutations That Improve the Fitness of A(H1N1)pdm09 Viruses Bearing the H275Y Neuraminidase Substitution;Journal of Virology;2022-08-10

2. Predicting potentially permissive substitutions that improve the fitness of A(H1N1)pdm09 viruses bearing the H275Y NA substitution;2021-03-21

3. EGCG induces β-defensin 3 against influenza A virus H1N1 by the MAPK signaling pathway;Experimental and Therapeutic Medicine;2020-07-24

4. Synthesis and Anti-influenza Activity of Novel Thiadiazole, Oxadiazole and Triazole Based Scaffolds;Letters in Drug Design & Discovery;2018-03-12

5. Antiviral Resistance in Influenza Viruses: Clinical and Epidemiological Aspects;Antimicrobial Drug Resistance;2017